• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Biohaven migraine drug sales again top Wall Street forecasts

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Oct 06, 2021 at 11:22: PM
via Sales of Biohaven Pharmaceutical's migraine medicine Nurtec ODT shot past Wall Street forecasts once again in the third quarter, as demand rose for the only treatment approved by the Food and Drug Administration for both treating and preventing the debilitating headaches.

article source
 




Top Bottom
Back
Quote